Hawaii Biotech, Inc. Reports Phase 1 Results for West Nile Virus Vaccine
2/25/2009 9:58:01 AM
HONOLULU--(BUSINESS WIRE)--Hawaii Biotech, Inc., today announced successful Phase 1 clinical trial results of its West Nile Virus vaccine in healthy volunteers. Hawaii Biotech is developing a West Nile recombinant sub-unit vaccine to induce protective immunity in recipients of the vaccine.
comments powered by